| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-07 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 7e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |